Waasmunster, Belgium

Frederik Pauwels

This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederik Pauwels. Retrieved from https://idiyas.com/inventor/frederik-pauwels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frederik Pauwels: Innovator in Hepatitis B Research

Introduction

Frederik Pauwels is an accomplished inventor based in Beerse, Belgium. He is currently associated with Janssen Pharmaceuticals, Inc., where he focuses on innovative solutions in the field of hepatitis B research. Despite having no granted patents to his name, his contributions to the field are noteworthy.

Latest Patent Applications

Frederik Pauwels has been involved in several significant patent applications. One of his latest applications is titled "Combination of Hepatitis B Virus (HBV) Vaccines and Capsid Assembly Modulators Being Sulfonamide Derivatives." This application describes therapeutic combinations of HBV vaccines and capsid assembly modulators. It outlines methods for inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals with chronic HBV infection. Another application is "Combination of Hepatitis B Virus (HBV) Vaccines and Dihydropyrimidine Derivatives as Capsid Assembly Modulators." Similar to the previous application, it details therapeutic combinations aimed at inducing an immune response against HBV and treating related diseases.

Conclusion

Frederik Pauwels is a dedicated inventor making strides in hepatitis B research through his innovative patent applications. His work at Janssen Pharmaceuticals, Inc. highlights his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…